You can see on the graph on the right, and this is from an earlier DOVETAIL ... So I think your questions are spot on. I mean 1 of the key differences between satralizumab and the known data on IGF-1R ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback